News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015
News Industry News In New Cardiac Surgery Study NephroCheck® Kidney Biomarkers Rise To The Occasion May 29, 2015
News Industry News Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat May 26, 2015
News Industry News CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference May 26, 2015